Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases

Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.

Asklepios places its first Social Schuldschein loan of EUR 500.0 million – Biotech Investments

EQS-News: Asklepios Kliniken / Key word(s): Financing Asklepios places its first Social Schuldschein loan of EUR 500.0 million 06.11.2024 / 10:00 CET/CEST The issuer is

November 7, 2024

Roche seeks to project confidence on its obesity drugs — and sees room to make its mark

LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ products — and that the

September 30, 2024

AbbVie’s next CEO; $100B club refresh; Top 100 VCs, 2023; More hope for CAR-T in autoimmune; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

February 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.